Published in J Virol on November 14, 2016
Papillomaviruses in the causation of human cancers - a brief historical account. Virology (2009) 5.46
Efficient intracellular assembly of papillomaviral vectors. J Virol (2004) 5.36
Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J (1991) 4.07
Human papillomavirus infection requires cell surface heparan sulfate. J Virol (2001) 3.32
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem (1999) 3.16
Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A (2006) 2.64
The biology and life-cycle of human papillomaviruses. Vaccine (2012) 2.53
Arrangement of L2 within the papillomavirus capsid. J Virol (2008) 2.37
A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol (2006) 2.16
The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol (1998) 2.12
Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. J Virol (2005) 2.07
Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol (2001) 2.02
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol (2007) 1.96
Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog (2009) 1.94
Cep68 and Cep215 (Cdk5rap2) are required for centrosome cohesion. J Cell Sci (2007) 1.78
Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog (2012) 1.76
Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J Virol (2008) 1.73
Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog (2008) 1.69
Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol (2006) 1.67
Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. J Biol Chem (2007) 1.66
Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs). PLoS One (2008) 1.63
Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol (2012) 1.58
Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog (2009) 1.57
Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J Virol (2006) 1.53
Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc Natl Acad Sci U S A (2013) 1.47
Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. J Virol (2005) 1.44
Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. J Gen Virol (1994) 1.44
An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates Golgi morphology and dendrite patterning. PLoS Biol (2011) 1.40
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS One (2012) 1.38
Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology (2002) 1.36
The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1. Am J Hum Genet (2009) 1.35
Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry. J Virol (2012) 1.34
Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J Virol (2013) 1.29
Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol (2011) 1.29
Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. J Virol (2004) 1.27
Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection. J Biol Chem (2003) 1.27
Assembly and translocation of papillomavirus capsid proteins. J Virol (2002) 1.26
CD151 regulates epithelial cell-cell adhesion through PKC- and Cdc42-dependent actin cytoskeletal reorganization. J Cell Biol (2003) 1.26
Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic (2012) 1.23
The evolving field of human papillomavirus receptor research: a review of binding and entry. J Virol (2013) 1.20
Obscurin-like 1, OBSL1, is a novel cytoskeletal protein related to obscurin. Genomics (2007) 1.19
Tetraspanin CD151 regulates RhoA activation and the dynamic stability of carcinoma cell-cell contacts. J Cell Sci (2009) 1.17
Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog (2014) 1.16
Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA. J Med Virol (2005) 1.15
Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization. Virology (2003) 1.14
Structural basis of oligosaccharide receptor recognition by human papillomavirus. J Biol Chem (2010) 1.13
Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res (2003) 1.11
Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol (2013) 1.11
Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2. J Gen Virol (1995) 1.11
A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection. J Virol (2012) 1.10
Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J Virol (2013) 1.08
Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection. PLoS Pathog (2015) 1.07
L2, the minor capsid protein of papillomavirus. Virology (2013) 1.07
Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16. J Virol (2013) 1.06
Mechanisms of cell entry by human papillomaviruses: an overview. Virol J (2010) 1.04
Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J Virol (2013) 1.01
Annexin-phospholipid interactions. Functional implications. Int J Mol Sci (2013) 1.01
Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity. MBio (2014) 1.00
Cellular receptor binding and entry of human papillomavirus. Virol J (2010) 0.99
The papillomavirus major capsid protein L1. Virology (2013) 0.98
Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol (2012) 0.92
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2. Am J Pathol (2008) 0.92
Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types. PLoS One (2013) 0.91
Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection. Antimicrob Agents Chemother (2011) 0.88
Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry. J Virol (2015) 0.87
Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells. J Virol (2015) 0.85
Identifying biological pathways that underlie primordial short stature using network analysis. J Mol Endocrinol (2014) 0.85
Inhibition by cellular vacuolar ATPase impairs human papillomavirus uncoating and infection. Antimicrob Agents Chemother (2014) 0.84
The extracellular δ-domain is essential for the formation of CD81 tetraspanin webs. Biophys J (2014) 0.84
Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein. Virology (2005) 0.84
Human papillomavirus species-specific interaction with the basement membrane-resident non-heparan sulfate receptor. Viruses (2014) 0.82
An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16. Cell Microbiol (2014) 0.81
The tetraspanin CD151 in papillomavirus infection. Viruses (2014) 0.81
The CD63-Syntenin-1 Complex Controls Post-Endocytic Trafficking of Oncogenic Human Papillomaviruses. Sci Rep (2016) 0.81
A Novel PDZ Domain Interaction Mediates the Binding between Human Papillomavirus 16 L2 and Sorting Nexin 27 and Modulates Virion Trafficking. J Virol (2015) 0.80
The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs. J Virol (2013) 0.79
Human papillomavirus infection requires the TSG101 component of the ESCRT machinery. Virology (2014) 0.79
The human papillomavirus-16 E7 oncoprotein exerts antiapoptotic effects via its physical interaction with the actin-binding protein gelsolin. Carcinogenesis (2013) 0.79
The cytoskeleton in papillomavirus infection. Viruses (2011) 0.78
Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection. Viruses (2015) 0.78
Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins. J Virol (2016) 0.76